EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study

Go back to EyeGate Pharma Announces Additional Positive Top-Line Data in PRK Pivotal Study
(NASDAQ: EYEG) Delayed: 33.99 -0.02 (0.06%)
Previous Close $34.01    52 Week High $5.09 
Open $33.99    52 Week Low $1.11 
Day High $33.99    P/E N/A 
Day Low $33.99    EPS $0.00 
Volume 20